MicroRNAs (miRNAs) are a recently discovered class of non-coding RNAs that are expressed in many cell types, where they regulate the expression of complementary RNAs, thus modulating the stability and translation of mRNAs. miRNAs are predicted to regulate the expression of ,50% of all protein coding genes in mammals. Therefore, they participate in virtually all cellular processes investigated so far. Altered miRNAs expressions are associated with both physiological (pregnancy) and pathological processes (cancer). As the dynamic maternal-fetal interface plays a critical role in the maintenance of successful pregnancy, it is not surprising that the miRNAs that are unique to reproductive tissues are abundantly expressed. Research in this field has demonstrated the presence and dysregulation of a distinct set of pregnancy-associated miRNAs; however, most studies have centered on localizing various miRNAs in reproductive microdomains associated with normal or complicated pregnancies. Although several independent miRNA regulatory mechanisms associated with endometrial receptivity, immune cells, angiogenesis and placental development have been studied, miRNA-mediated regulation of pregnancy remains poorly understood. This review provides a summary of the current data on miRNA regulation as well as functional profiles of miRNAs that are found in the uterus, in immune cells associated with maternal tolerance to the fetus, and those involved in angiogenesis and placental development.
INTRODUCTION
Only two decades ago, the majority of the non-coding regions in the genome of a species were considered to be 'junk' DNA. Any regions of DNA that did not bind promoters, enhancers or repressors, were not thought to be useful for anything. However, our perception of these regions has profoundly changed as a result of the discovery of lin-4, the first microRNA (miRNA) in Caenorhabditis elegans by Lee, Feinbaum and Ambros just over 20 years ago. 1 The discovery of miRNAs has provided much insight into the regulation of gene expression, which affects many biological processes including mammalian reproduction.
2-6 miRNAs are small non-coding RNAs 18-22 nucleotides in length that serve to negatively regulate translation of complementary RNAs by either repressing the translational machinery of the ribosome or by deadenylating and hence destabilizing the mRNA, reviewed in. 7 Over 2000 mature human miRNA sequences have been reported, and they are postulated to fine tune gene expression of ,50% of all protein coding genes. 7 The majority of miRNAs are highly conserved across mammalian species, 8 and each miRNA has the potential to repress the expression of several target genes, highlighting their intricate regulation of gene expression. Their conservation indicates the importance in regulating many biological processes including cellular differentiation, proliferation and apoptosis. Since their discovery, miRNAs have emerged as major bioregulatory molecules of various processes including pregnancy.
between the maternal immune cells and fetal trophoblasts at least in hemochorial placentation must occur to allow for placental development and initiation of blood vessel development. During early pregnancy, the maternal endometrium becomes populated with immune cells, particularly natural killer (NK) cells, T cells, B cells, macrophages and dendritic cells 12 that adopt specialized phenotypes. These cells assist in maintaining physiological homeostasis, placentation and tolerance against the semi-allogeneic fetus. Extensive literature documents the presence of immune cells at the maternal-fetal interface. [13] [14] [15] [16] [17] [18] [19] However, it is not entirely clear how these immune cells are recruited or their pregnancy specific functions. Studies over the past few decades have suggested the presence of progenitor stem cells in the uterus that differentiate during early pregnancy 20 and/or that immune cells are recruited from the peripheral blood by conceptus-dependent or -independent signals. [21] [22] [23] [24] The underlying mechanisms associated with placental development and functions are complex and comprise of intricate regulatory pathways. 25, 26 Previous studies have documented the role of many protein-coding genes in the context of pregnancy, reviewed in. 27 However, the miRNA networks in the context of the immunological mechanisms associated with pregnancy are poorly characterized. As such, a better understanding of miRNAs, their regulation and functions will greatly enhance our ability to comprehend both physiological and pathological phenomena. Here, we explore and review the current literature surrounding miRNAs as well as our own research as it relates to reproductive biology, focusing primarily on miRNA regulatory action, immune tolerance at the maternal-fetal interface and the uterine-placental miRNA signatures.
MICRORNA BIOGENESIS AND MECHANISM OF ACTION
The mechanisms of miRNA biogenesis and mRNA target repression have been extensively studied in recent years. miRNAs are mainly transcribed by RNA polymerase II which cleaves the long primary transcripts (pri-miRNAs) of the genes.
2,27,28 While some primary miRNA transcripts are contained within introns and produce a single miRNA, others are within exons and produce several miRNAs. 28 After transcription, the long pri-miRNAs are cleaved by the enzymes Drosha (RNase III endonuclease) and DiGeorge syndrome critical region gene 8 that together form a microprocessor complex in the nucleus and result in the formation of pre-cursor miRNAs (pre-miRNAs, 60-70 nucleotides). The pre-miRNAs are then transported out of nucleus by Exportin 5. Upon entering the cytoplasm, the pre-miRNAs are further processed by Dicer (RNase III enzyme) into miRNA duplexes. 29 Subsequently, the miRNA duplex is unwound leaving single strands, one of which will function as a mature miRNA (,20 nucleotides). Finally, the mature miRNAs are loaded into the Argonaute protein containing RNA-induced silencing complex for mRNA target recognition. 29, 30 miRNA regulation of gene expression is largely controlled by the mature miRNAs which post-transcriptionally target mRNAs and result in either the degradation of their target mRNA or repression of protein translation. The degradation of mRNA or translational repression occurs when the miRNA-RNA-induced silencing complex binds to specific sites in the 39-untranslated region of target mRNA. 31 Recent studies strongly support the inhibition of translation as the main mechanism through which miRNAs repress mRNA function. However, the type of post-transcriptional control depends on how the miRNA interacts with its target mRNA. The miRNAs associate with the mRNAs by the complementary pairing between a seed sequence (2-7 nucleotide) within the miRNA and the 39-untranslated region of the target mRNA. 32 This interaction can be exactly complementary, or nearly exact, and lead to cleavage and degradation of the mRNA, or it can be imperfect and lead to translational repression. As a result, one miRNA is able to regulate multiple mRNAs and, in turn, one mRNA can be regulated by multiple miRNAs. While the majority of the literature suggests an inhibitory role for miRNAs in gene regulation, some studies have explored alternate mechanisms that result in the fine tuning of gene expression in diverse developmental settings. 33 
MICRORNA REGULATION IN THE UTERUS
Much of the current literature focuses on the dysregulation of miRNAs in many pathological conditions, but miRNAs also control many important physiological processes such as pregnancy. We are only beginning to discover the roles of miRNAs in reproduction. miRNAs have been implicated in endometrial receptivity, [34] [35] [36] implantation, 37-42 labor [43] [44] [45] [46] [47] and even spontaneous fetal loss in the pig. 48, 49 In the uterus, most of the physiological changes occurring over the estrous/menstrual cycle and during pregnancy are driven by the ovarian hormones. In other organs and tissues, research has shown that there are many opportunities to regulate miRNAs; their transcription, processing, RNA editing, function and intracellular localization can all be modified, and thus affect miRNA binding of mRNAs (reviewed in. Refs. 7, 50 and 51). Within the uterus, both estrogen and progesterone are able to regulate miRNA expression directly and indirectly by enhancing or repressing these processes. [52] [53] [54] [55] [56] [57] Estrogen, one of the major reproductive hormones, regulates miRNA in endometrial cells and the uterus. [52] [53] [54] [55] [56] [57] It can directly regulate miRNAs by binding estrogen receptor 1 and modifying the consortium of cofactors recruited, either promoting or suppressing their transcription. 58 Nothnick and Healy 55 showed that the effect of estradiol (E 2 ) on the uterine expression of miRNAs can be in either direction; in mice exposed to E 2 , miR-451, -429, -99b, -155 and -7a are increased, while miR-24 and -181b are decreased. In the same experiment, the effect was abrogated by concurrent treatment with ICI-182-780, an estrogen receptor antagonist, indicating that the effect was dependent upon E 2 -estrogen receptor interactions. Alternatively, estrogen can indirectly regulate miRNA maturation by altering concentrations of the biosynthetic or miRNA transport components: Drosha, Dicer and Exportin. 56, 59 For instance, the maturation of several miRNAs in the mouse uterus was inhibited by E 2 -estrogen receptor 1 repression of Drosha processing. 59 Additionally, E 2 rapidly increases Exportin-5 in the uterus, within 4-8 h post-treatment. 56 Progesterone is also able to increase transport of uterine miRNAs by increasing Exportin-5 expression. 56 When estrogen and progesterone are combined, a synergistic effect is observed. Dicer, Drosha, and Exportin-5 are all increased in the uterus as a result of combined estrogen and progesterone treatment, while antagonists (ICI-182-780 and RU486) blocked the effect. 56 Thus, both estrogen and progesterone are able to modulate miRNA expression in the uterus, mainly via interaction with the nuclear steroid receptors which then rapidly increase the bioavailability or expression of miRNA processing machinery and transporters. Ultimately, it seems that the effect of the steroid hormones in the uterus is to expedite the conversion of pri-to pre-miRNAs, the transport of pre-miRs to the cytoplasm, and the processing of pre-to mature miRNAs, all serving to increase the bioavailability of mature miRNAs. The regulation of miRNAs by both gonadal hormones suggests that miRNAs are important regulators of mRNA translation in the reproductive system and during pregnancy. Interestingly, the regulation of miRNA processing and expression is reported to be at least partly under ovarian steroid hormone control 52, 53, [55] [56] [57] 59 and generally, miRNA expression is repressed.
MICRORNAS AND IMMUNE CELLS AT THE MATERNAL-FETAL INTERFACE
The paradoxical nature of mammalian pregnancy, where an intimate immunological relationship exists between mother and allogeneic fetus was recognized in the 1950s by Peter Medawar. 60 The implantation site is the main location where the blastocyst establishes physical contact with the endometrium resulting in maternal allorecognition of the fetal antigens. Blastocyst implantation occurs at 7 days post-coitum in humans and 4.5 days post-coitum in mice. The extravillous trophoblast cells of the conceptus invade into the uterine endometrium and intermingle with the leukocytes. Approximately 70% of the leukocytes in early decidua are uterine NK cells that are likely involved in fine tuning placental development, vascularity and subsequently fetal growth. [61] [62] [63] Unlike most cells of the human body, trophoblasts have limited or poor expression of the major histocompatibility antigens-human leukocyte antigen (HLA)-A and -B that are highly polymorphic. Limited or poor expression of HLA-A and -B is postulated to support the development of maternal tolerance to the fetus during pregnancy. Other HLA isoforms, HLA-G and HLA-C, are the main molecules expressed by the trophoblasts. HLA-G has five alleles 64 and HLA-C has two major alleles. 13, 65 These molecules interact with maternal killer immunoglobulin-like receptors (KIRs), KIR-A and KIR-B, 66 expressed by uterine NK cells and result in immunological tolerance. The tolerogenic properties of HLA-G have been explored in various immunological disciplines other than pregnancy, namely transplantation research and cancer. In 2007,Tan et al. 67 showed that miR-152 regulates the expression of HLA-G of extravillous trophoblast origin in children with asthma. However, it had previously been demonstrated in the context of pregnancy that HLA-G expressed mainly by the extravillous trophoblasts of the placenta could be downregulated by miR-148a and miR-152 by binding to its 39-untranslated region. 68 Similarly miR-152 has been shown to repress HLA-G without affecting the invasiveness of JEG-3 choriocarcinoma cells. 69 In addition, NK cell-mediated cytolysis was increased by overexpression of miR-152 69 and the downregulation of HLA-G-affected LILRB1 (inhibitory receptor) recognition, which resulted in enhanced killing activity of NK cells. 68 These studies further suggest a major role for miR-152 in mediating immune responses. In a more recent study, activated CD4
1 T lymphocytes cultured in the presence or absence of HLA-G were screened for 87 miRNAs and it was found that miR-451 and miR-210 were modulated by soluble HLA-G. 70 The interaction between miR-148 and HLA-C has been reported in studies of HIV infection. 71 Although miR-148 targeting of HLA-C has not been studied in the context of trophoblast cells or pregnancy, it has been reported that HLA-C is expressed by invading trophoblast cells. 65, 66 Thus, miR-148 may a play a role in regulating the expression of HLA-C in trophoblasts where further investigations are warranted. Taken together, these results indicate that miRNAs are involved in the immunological mechanisms associated with human pregnancy, and they pave the way toward further research in this area.
Although several studies have profiled miRNAs in individual cell types, especially cells of the immune system, very little information is available on miRNA expression in the individual cell types of the decidua or the immune cells present at the maternal-fetal interface. A recent study demonstrated temporal and spatial regulation of let-7a and miR-320 that were differentially expressed in the rat uterus with expression affected by decidualization during the window of embryo implantation. 72, 73 Additionally, a subset of miRNAs (hsa-miR-222, 221, 181b, 27b, 29b, 507, 143, 101, 30d, 30c and 23a) participates in gene reprogramming during endometrial stromal cell (ESC) decidualization in vitro and hsa-miR-222 was found to play a key role in differentiation of ESCs by regulating their terminal withdrawal from the cell cycle. 74 In our laboratory, studies on spontaneous fetal loss in pigs have provided evidence of selective miRNA expression in endometrial lymphocytes (unpublished data). Our research shows that miRNAs reported to be involved in immune cell development and angiogenesis (miR-150, miR-17-5P, miR-18a, miR-19a and miR-296-5P) differ significantly between endometrial lymphocytes isolated by laser capture microdissection from conceptus attachment sites associated with growth arrest compared with healthy embryos (unpublished data). These findings indicate that miRNAs that are involved in immune cell development and in angiogenesis may be selectively regulating the placental development as well as subsequent conceptus viability in pigs and thus, they could set the uterine lineage as distinct from circulation or other organs. We previously identified specific miRNAs associated with spontaneous fetal loss in the pig. 49 As miRNAs are found within the individual placental immune cells and within uterine environment during pregnancy, they miRNAs and pregnancy M Bidarimath et al are capable of regulating the fine balance between the mother and her offspring, and likely help to regulate successful placentation and pregnancy.
MICRORNA REGULATION IN THE PLACENTA
MicroRNAs are highly expressed in the placenta throughout most mammalian pregnancy. [75] [76] [77] Placental miRNAs are crucial for the regulation of the ever-changing placental environment as well as its development. [78] [79] [80] 
At this point in time, the regulation of miRNAs in the placenta is not entirely clear. Many studies have investigated miRNA regulation of gene expression in the context of various pathologies, particularly those affecting humans. These include fetal weight restriction and low fetal birth weight (intrauterine growth retardation or IUGR), [81] [82] [83] [84] toxin exposures such as environmental toxins, 85, 86 cancer (hepatocellular carcinoma), 87 diabetes mellitus 88 and, the most heavily studied, human pre-eclampsia. 79, [89] [90] [91] [92] [93] [94] [95] [96] Many of the pre-eclampsia studies have investigated miRNA expression using high throughput microarray, and qPCR (primarily in order to validate specific microarray findings). Previous studies have established that oxygen tension is implicated in placental development in humans and mice. 89, 90, [97] [98] [99] Traditionally, hypoxia inducible factor-alpha (HIF-1a) has been associated with regulation of placental cell differentiation in vivo. 90, 97 In addition to HIF-1a, the heme oxygenase family has been found to have a direct dependence on oxygen availability, as well as in the downregulation of several crucial genes involved in angiogenesis. 98 Recent studies have outlined how miR-210 is specifically implicated in pre-eclampsia, a condition of systemic endothelial inflammation that occurs after mid-pregnancy in humans. miR-210 was found to be upregulated in trophoblast cells cultured under hypoxic conditions, and in pre-eclamptic patients as compared to healthy controls. 91, 100 Interestingly, another study found that miR-210 expression under hypoxia can be regulated by the p50 transcription factor, which in turn regulates HIF-1a in the trophoblast cells. 91 Therefore, miRNAs share regulatory pathways with other placental genes that are altered in pre-eclampsia. 91 In addition to miR-210, other important miRNAs including the miR-17-92 family, which is involved in angiogenesis 101, 102 and immune cell development, 103 miR-93, miR-205, miR-335, miR-224, miR-424, miR-451 and miR-491 have been found to be differentially expressed in primary human trophoblasts that were exposed to hypoxia. 104 Additionally, miR-205 has been found to be linked to placental development in humans. 104 miR-205 silenced mediator complex coregulator, or MED1 in primary human trophoblasts that were subjected to hypoxic conditions. Since MED1 is established as a regulator of placental development, it may serve as a mediator in pre-eclampsia. 104 Due to their dysregulation under hypoxic conditions, it seems likely that multiple miRNAs are important for the various functions of the placenta. 104 This is further supported by the fact that miRNAs have multiple roles and share regulatory pathways in the placenta. 91, 104 The involvement of miRNAs in human trophoblast differentiation was demonstrated recently when the members of the miR-17-92 cluster as well as the miR-106a-363 family, which are regulated by c-myc oncoprotein, were found to inhibit trophoblast differentiation via repression of aromatase (hCYP19A1) and the transcription factor responsible for murine labyrinthine trophoblast development (human GCM1 or hGCM1). 105 Another miRNA, miR-29b, that appears to have a similar role to the miR-17-92 cluster, has also been implicated in pre-eclampsia. 106 miR-29b is involved in apoptosis, angiogenesis, and trophoblast invasion. 106 miR-29b regulates the expression of induced myeloid leukemia cell differentiation protein, as well as matrix metalloproteinase-2, and the angiogenic gene, vascular endothelial growth factor (VEGF) A and ITGB1 (integrin beta1) genes. This suggests that miR-29b is involved in the regulation of placental functions including invasion, apoptosis and angiogenesis. 106 Cumulatively, these studies suggest that many different miRNAs present in trophoblast cell populations might contribute to the pathogenesis of pre-eclampsia.
MicroRNAs perform multiple functions during placental development. They can exert their actions by binding to target genes responsible for cellular invasion, proliferation, apoptosis and angiogenesis. One major way for accomplishing this is by targeting Nodal, which is an important gene involved in early embryogenesis as well as cell differentiation. 107 There are many miRNAs that are differentially expressed between the first and third trimesters of human pregnancy as demonstrated by in vitro experiments on first and third trimester cell lines. 9 Additionally, certain families of miRNAs are clustered together in chromosomal regions. As a result, although many of the miRNAs found to be differentially expressed in the placenta have different targets, they may be controlled by the same promoters and work in a synergistic manner. 10, 108 Three miRNA clusters have recently been assessed as potential biomarkers of placenta-related pregnancy disorders such as pre-term labor, and pre-eclampsia. These clusters include C19MC, miR-371-3 (both located on chromosome 19) and C14 (located on chromosome 14). 10, 108 The C19MC miRNA cluster (the most extensively researched of the three) is expressed in trophoblast and placenta-derived stromal cells. 109 Previously, three miRNAs from the C19MC family, miR517a-3P, miR519a-3P and miR-520c-3P, were found in the choriocarcinoma trophoblast cell lines JEG-3 and BeWo. However, the HTR8/SVneo first trimester trophoblast cell line did not express these miRNAs. 9 From this group of miRNAs, miR-519-3P was recently shown to target Calcineurin subunit B type 1 miRNAs and pregnancy M Bidarimath et al (PPP3R1) and to encode a regulatory subunit of calcineurin in the human trophoblast. 110 These studies illustrate the importance of the C19MC miRNA cluster in human placenta.
Another exciting discovery was the presence of miRNAs in human placental exosomes. 111, 112 Exosomes are microvesicles secreted by cells as a mechanism of intercellular communication. Exosomes from the placental syncytiotrophoblasts are released into the circulation and are present at the shared placental intervillous space between the fetus and its mother. Much akin to miRNAs, exosomes were traditionally believed to be a mechanism of cellular waste/disposal transport, but miRNAs, specifically C19MC, are abundantly released from primary human trophoblasts. 111 Exosomes containing the C19MC miRNA cluster infer viral resistance to recipient cells through autophagy, 113 and may help immunologically protect the developing fetus. These recent studies illustrate that exosomes may play an important role in maternal-fetal exchange, 111, 114 as well as in embryo implantation through maternal-fetal cross-talk. 112 The most abundant miRNAs in placental exosomes are miR-17, miR-106a and miR-200c. 112 Using bioinformatics analysis, Ng et al. 112 showed that exosome-specific miRNAs share common targets that were previously implicated in embryo implantation. 112 Future research in this field will reveal the importance of exosomal miRNA with respect to gene regulation in the placenta and in fetomaternal exchange. Such research will determine whether or not there is an overlap between miRNA regulation of gene expression and other forms of gene regulation (mRNA destabilizing/stabilizing factors).
The C19MC gene cluster including miR-21, miR-155 and miR-519d target genes associated with apoptosis/tumor suppression such as protein kinase B gamma (AKT3), tissue inhibitor of metalloproteinases-3(TIMP3), cyclin-dependent kinase inhibitor 1 (CDKN1A/p21), and importantly, phosphatase and tensin homolog (PTEN) targeted by all three miRNAs. 10, 87, 115 The suppressive effects of miR-155 can regulate PTEN in a first trimester human trophoblast cell line (HTR8/SVneo), and can thus aid in the regulation of apoptosis through the AP-1/NF-kB pathway. 115 In a similar study, miR-21 was shown to have a direct regulatory effect on PTEN, since miR-21 overexpression in a third trimester human placental cell line downregulated PTEN mRNA and protein. 81 Our laboratory identified miRNAs associated with spontaneous fetal losses in pigs. 49 The pig serves as a unique model for pregnancy research due to its epitheliochorial type of placentation. This maternal-fetal interface differs from that of humans and mice (hemochorial placentation), since there is no invasion of the maternal tissues by the trophoblasts and no decidualization of the maternal endometrial stroma. Therefore, we can obtain distinct miRNA profiles from maternal and fetal tissues without cross-contamination of cells. Recently, we characterized selected expression of miRNAs (miR-15b-5P, miR-222 and miR-18a; unpublished data) in trophoblasts isolated from attachment sites containing growth restricted versus healthy conceptuses. These findings provide new information on spontaneous fetal loss, which is common in North American breeds of swine.
MICRORNA REGULATION OF ANGIOGENESIS
By most appraisals, angiogenesis is a key physiological process during pregnancy. Regulation of angiogenesis by miRNAs occurs in both physiological and pathological conditions where both pro-and anti-angiogenic mRNAs can be targeted. 116 The most widely studied pro-angiogenic factor is VEGF, and miRNA-mediated control over angiogenesis, specifically by modulating VEGF transcripts, has been demonstrated. [117] [118] [119] [120] [121] While there are many pro-and anti-angiogenic miRNAs, each member of the miRNA-17-92 cluster (miR-17, -18a, -19a, -19b , -20a and -92a), has been shown to have anti-angiogenic effects on endothelial cell sprouting in vitro and inhibition of these miRNAs increased endothelial sprouting. 122 This effect can also be seen in vivo in a mouse lung cancer model where systemic blockade of the miR-17-92 cluster promoted tumor neovascularization. 122 The precise mechanism through which the miR-17-92 cluster inhibits angiogenesis is unknown, and may be multifaceted. First, VEGF is a direct target of some cluster members in human nasopharyngeal carcinoma cells. 117 Second, they also target the VEGF transcription factor, HIF-1a. 123, 124 Third, these miRNAs are reported to regulate VEGF-mediated endothelial cell migration via the MEK/MAPK pathway. 125 Cancer cells exploit miRNA regulation of angiogenesis and promote tumor growth by downregulating VEGF-targeting miRNAs (miR-17, -20, -199a and -125b), 118, 121 tipping the scale towards conditions favoring angiogenesis. Not only does miR-125b target VEGF, but it also targets placental growth factor, another angiogenic factor, in hepatocellular cancer. 126 Therapeutically, the overexpression of miR-199a and -125b in ovarian cancer cells reduces VEGF and thus angiogenesis. 121 While much of the current literature focuses on miRNA regulation of angiogenesis in cancer, some evidence implicates miRNAs in angiogenesis in reproductive pathologies. In patients with pre-eclampsia, placental angiogenesis is inadequate, and the underdeveloped vasculature is associated with an upregulation of miRNAs (miR-17, -20a, -20b, 127 miR29b 106 and miR-182*
128
) that target VEGF, and thus inhibit angiogenesis. A recent study has assessed the therapeutic efficacy of miR-126, a pro-angiogenic miRNA, in reversing the inadequate vasculogenesis that occurs in pre-eclampsia. 129 In a pre-eclamptic rat model, miR-126 replacement therapy by agomiR-126 increased placental area, weight and microvessel density compared to saline-injected control animals. 129 The underexpression of VEGF-targeting miRNAs in pathologies associated with abundant angiogenesis and the overexpression of miRNAs in pathologies associated with insufficient angiogenesis suggest important roles for miRNAs in controlling angiogenesis.
Placental villi from women with recurrent spontaneous abortion have increased levels of several miRNAs when compared to controls, including the VEGF-targeting miR-125b. 130 Additionally, our previous work identified endometrial dysregulation of several miRNAs including miR-10a, 49 which has miRNAs and pregnancy M Bidarimath et al been associated with angiogenesis 131 and endothelial cell inflammation, 132 in porcine spontaneous fetal loss. Under physiological conditions including pregnancy, an appropriate array of angiogenic miRNAs is likely required. Thus, an offset in this balance might contribute to some of the pathologies of pregnancy. In the pig, a variety of VEGF-targeting miRNAs (miR-17, -20, -92b and -125b) are differentially expressed between gestation days 30 and 90, 133 and in our study profiling miRNAs at the porcine maternal-fetal interface, we identify regulation of blood vessel development/angiogenesis as being the third most important functional cluster increased in endometrium from pregnant pigs versus non-pregnant pigs. 49 Taken together, miRNA regulation of angiogenesis participates in both pathological and physiological angiogenesis, and offers a novel therapeutic avenue to explore.
CONCLUSIONS AND PERSPECTIVES
Several lines of evidence support a central role for miRNAs in regulating the pathways controlling fundamental cellular processes associated with pregnancy success and failure. However, miRNA-mediated repression of the uterine transcriptome in pregnancy is not entirely clear. Further investigations are required to explore the functional implications of miRNAs in successful pregnancy. Cells of the immune system play an absolutely critical role in establishing maternal tolerance against the allogeneic fetus and in supporting uterine vascular transformation during pregnancy. So far, very few studies have investigated the role of specific miRNAs in various immune cell types at the maternal-fetal interface or their involvement in regulation of immune cell development. Since each miRNA is predicted to interact with many mRNAs and each mRNA in turn miR-10a, -27a, -29c, -323, -331-5p, -339-3p, -374b-5p, and -935 49 Placental Let-7a and miR-320 72, 73 Uterine miRNAs
Angiogenic miRNAs miR-517a-3p, 519a-3p, and -520c- While much of the current literature focuses on human and mouse pregnancy, the conserved nature of miRNAs across species suggest that they are likely universally involved in pregnancy, placentation, immune tolerance and angiogenesis at the maternal-fetal interface. As negative regulators of gene expression miRNAs are poised to have profound effects during pregnancy, and their dysregulation has already been associated with reproductive pathologies. Here presented is a short list of the miRNAs documented in this review as they relate to location (uterus, placenta or immune cells) or function (angiogenesis) during pregnancy in a variety of species. miRNA, microRNA.
interacts with many miRNAs, it is critical to understand their regulation in order to maintain the delicate balance between successful and unsuccessful pregnancy. Here (Figure 1) , we have summarized the current literature, highlighting miRNAs found in the uterus and immune cells and identifying those involved in angiogenesis and placental development. 
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